Journal of Pharmaceutical Investigation
短名 | J. Pharm. Investig. |
Journal Impact | 5.12 |
国际分区 | PHARMACOLOGY & PHARMACY(Q1) |
期刊索引 | SCI Q1中科院 4 区 |
ISSN | 2093-5552, 2093-6214 |
h-index | 39 |
国内分区 | 医学(4区)医学药学(3区) |
Journal of Pharmaceutical Investigation(J. Pharm. Investig.), the official journal of the Korean Society of Pharmaceutical Sciences and Technology, is an international, peer-reviewed journal that covers all pharmaceutical sciences, including engineering, regulatory, physicochemical, biological, and microbiological studies related to the conception, design, production, characterization and evaluation of pharmaceutical products and drug delivery systems. It is a bimonthly journal published in January, March, May, July, September, and November. All manuscript should be creative and informative for pharmaceutical scientists, and should contain advanced knowledge in clear and concise English. Articles in the following categories are published: Research articles, Notes, Information, and Reviews.(Formerly Journal of Korean Pharmaceutical Sciences: ISSN 0259-2347)
期刊主页投稿网址涉及主题 | 化学生物医学有机化学生物化学药理学材料科学物理色谱法内科学工程类遗传学化学工程复合材料心理学物理化学生物信息学内分泌学量子力学纳米技术精神科核磁共振药品 |
出版信息 | 出版商: Springer Netherlands,出版周期: 6 issues per year,期刊类型: journal |
基本数据 | 创刊年份: 2012,原创研究文献占比: 49.15%,自引率:7.50%, Gold OA占比: 4.67% |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Extracellular vesicles as drug delivery systems in therapeutics: current strategies and future challenges
2024-9-2
Nitric oxide-releasing albumin/chondroitin sulfate bioadhesive dressing for the treatment of MRSA-infected wounds
2024-9-2
Zwitterionic alginate derivative as a new delivery platform for enhanced blood circulation
2024-8-30
Emerging trends in quantum dot-based photosensitizers for enhanced photodynamic therapy in cancer treatment
2024-8-27
Layered double hydroxide Pickering emulsion with enhanced skin penetration and photostability for psoriasis treatment
2024-8-26
A precise look at electrospinning parameters in fabricating the polymeric nanofibers: a review on synthetic and natural polymers
2024-8-24
A review of recent advances in nanotechnology for the delivery of therapeutics in wound healing
2024-8-19
Attenuation of high-fat high-sucrose diet and CCl4-induced non-alcoholic steatohepatitis in rats by activating autophagy and SIGMAR1/GRP78/ITPR1 signaling using berberine-loaded albumin nanoparticles: in vivo prediction and in-silico molecular modeling
2024-8-16
Transdermal fluocinolone acetonide loaded decorated hyalurosomes cellulose acetate/polycaprolactone nanofibers mitigated Freund’s adjuvant-induced rheumatoid arthritis in rats
2024-8-12
Enhanced oral bioavailability of megestrol acetate via polymer-hybridized solid lipid nanoparticles using ultrasonic nebulization method
2024-8-8
Nanoparticle-integrated metal–organic frameworks: a revolution in next-generation drug delivery systems
2024-8-2
Current advances and future perspectives of fattigation technology in pharmaceutical sciences and drug delivery
2024-7-19
Development and evaluation of dexamethasone-loaded bioadhesive polymeric nanocapsules for mitigating cardiac and gastric adverse effects of free dexamethasone
2024-7-16
Formulation and in vitro/in vivo characterization of a fixed-dose combination tablet of dapagliflozin and rosuvastatin
2024-7-5
Recent advances in albumin nanoparticle-based cancer therapies
2024-7-5
Indocyanine green-loaded microspheres as a near-infrared fluorescence marker for long-term localization of tumor sites
2024-6-25
Advancements of hot-melt extrusion technology to address unmet patient needs and pharmaceutical quality aspects
2024-6-22
™Injectable hydrogel systems for local cancer therapy
2024-6-14
Formulation and evaluation of ivermectin-loaded dissolving microarray patches for rosacea disease
2024-6-3
Integration of modern science into herbal medicine: application of pharmacokinetic-pharmacodynamic modeling in understanding nonclinical study of Cinnamomum cassia extract.
2024-6-1
Preparation of semaglutide long-acting injectable microcapsules with physicochemical properties, long-term stability, and pharmacokinetics and pharmacodynamics
2024-5-29
Cell membrane camouflaged nanoparticle strategy and its application in brain disease: a review
2024-5-22
Layered silicate nanoparticles as a non-injectable drug delivery system for biomacromolecules
2024-4-23
Development and in vitro/in vivo evaluation of a nanosponge formulation loaded with Boswellia carterii oil extracts for the enhanced anti-inflammatory activity for the management of respiratory allergies
2024-4-8
Lyotropic liquid crystalline nanoparticles for oral delivery: formulation and evaluation of sustained-released cromolyn sodium loaded cubosomes
2024-4-4
High payload dexamethasone palmitate-loaded solid lipid nanoparticles for enhanced anti-inflammatory effects in acute skin inflammation model
2024-3-19
Development of a self-microemulsifying drug delivery system using a Dunnione to enhance bioavailability
2024-3-12
Safety of applying influenza-antigen-coated microneedles to rat skin and the antigen specific immune response in vivo
2024-3-7
Preformulation and evaluation of multi-layer tablets
2024-3-1
Oligonucleotide therapeutics and their chemical modification strategies for clinical applications
2024-2-29
Applications of the design of additive manufacturing (DfAM) in the development of pharmaceutical dosage forms
2024-2-28
Blocking Fas signaling in adipose tissue ameliorates obesity-associated inflammation, insulin resistance, and hepatosteatosis
2024-2-22
Atorvastatin loaded lecithin-coated zein nanoparticles based thermogel for the intra-articular management of osteoarthritis: in-silico, in-vitro, and in-vivo studies
2024-2-20
Pharmacokinetics and extensive intestinal first-pass effects of apigenin and its active metabolite, apigenin-7-O-glucuronide, in rats
2024-2-17
A review on the nanotechnology-based approaches for managing sexually transmitted infections
2024-2-16
Perfluorocarbon-based artificial oxygen carriers for red blood cell substitutes: considerations and direction of technology
2024-2-16
Organic clay-based fast dissolving microneedles for efficient transdermal delivery of therapeutic proteins
2024-2-14
Intranasal delivery of siRNA targeting NR2B attenuates cancer-associated neuropathic pain
2024-2-13
Biocompatible biodegradable polymeric nanocarriers in dry powder inhalers (DPIs) for pulmonary inhalation delivery
2024-2-8
Impact of 1α,25-dihydroxyvitamin D3 on biodistribution and pharmacokinetics of L-carnitine and creatinine, organic cation/carnitine transporter 2 and organic cation transporter 2 biomarkers
2024-2-7
Cancer cell membrane-decorated hybrid liposomes for treating metastatic breast cancer based on enhanced cancer immunotherapy
2024-1-31
Exploring pharmacokinetics and herb-drug interactions of an herbal extract mixture derived from Poria cocos and Morus alba L.
2024-1-24
Recent approaches to investigate drug delivery systems through the lymphatic pathway using oral lipid-based formulations
2024-1-24
Development of abiraterone acetate tablets with enhanced oral bioavailability
2024-1-9
Multicompartmental pharmacokinetic evaluation of enavogliflozin eye drop formulation: Understanding its distribution to posterior segments
2024-1-8
A two-step design of experiments approach to investigate the simultaneous effects of ion-pairing and chemical enhancers to improve the permeability of lornoxicam in a topical hydrogel patch
2024-1-8
Transferrin modified PEG–PLGA nanoparticles: highly effective notoginsenoside R1 formulations for the treatment of ulcerative colitis
2024-1-4
Applying polyvinyl alcohol to the preparation of various nanoparticles
2024-1-3
Evaluation of a spray-dried amorphous solid dispersion formulation of ID11916, a new molecular entity with dual inhibition mechanisms targeting the androgen receptor and phosphodiesterase type-5
2023-12-28
Strategic design and clinical evaluation of a fixed-dose combination tablet comprising valsartan, amlodipine, rosuvastatin and ezetimibe for patients with hypertension and dyslipidemia
2023-12-20
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远